SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (5457)10/5/1998 10:05:00 PM
From: margie  Read Replies (1) of 6136
 
There is a documentary history of polio on PBS now. "A Paralyzing Fear", It is being broadcast now, nationwide on
PBS stations Monday, October 5, 1998, at 9:00 pm
to 11:00 p.m. in the Eastern time zone. Further
information is available at pbs.org
Sorry for this late notice.
With Salk, of course.

The story of the polio vaccine reveals insightful
parallels and contrasts with ongoing issues, events,
and controversies surrounding the development of
AIDS vaccines.

_________________________________-

The stockholder rights plan, from the June 97 10-K

I didn't realize all the typos there were in that link, so here it is corrected. I was wondering myself what a 155 was- it was supposed to be 15% and a 505 - 50%.

"On November 7, 1996, the Board of Directors of the Company adopted a Stockholder rights Plan. Under the terms of the Plan, stockholders of record as of November 21, 1996 received a dividend of one Preferred Stock Purchase right ("Right(s)") for each share of common stock held on that date. The rights will expire 10 years after issuance, and will be exercisable only if a person or group becomes the beneficial owner of 15% or more of the common stock (such person or group, a "15% holder") or commences a tender or exchange offer which would result in the offeror beneficially owning 15% or more of the common stock. Each Right will entitle stockholders to buy one one-ten thousandth of a share of Series B Participating Preferred Stock of the company at an exercise price of $500.00 per share subject to certain anti-dilution adjustments.

If a person or group accumulates 15% or more of the common stock, each right (other than Rights held by a 15% holder and certain related parties, which will be voided) will be adjusted so that upon exercise the holder will have the right to receive that number of shares of common stock (or in certain circumstances, a combination of securities and/or assets) having a value of twice the exercise price of the right. In addition, if following the public announcement of the existence of a 15% holder the Company is involved in a merger or business combination or a sale of 50% or more of the Company's assets or earning power, each right (other than rights held by a 15% holder and certain related parties, which will be voided) will represent the right to purchase, at the exercise price, common stock of the acquiring entity having a value of twice the exercise price at the time. The board of Directors will also have the right, following the public announcement of the existence of a 15% holder, to cause each Right, (other than rights held by the 15% holder) to be exchanged for one share of common Stock.

The Board of Directors is entitled to redeem the Rights at $0.001 per right at any time prior to the public announcement of the existence of a 15% holder.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext